Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUMO study of luteal phase support in MOH/IUI
NL-OMON24508Not yet recruiting
- Sponsor
- ZonMw
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of progesterone in Unexplained infertility (2 arms), sponsored by ZonMw. Primary endpoint: Live birth within 6 months. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
progesterone
03
Conditions
Unexplained infertility
Beyond the preview
Go deeper on NL-OMON24508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24508.